Consistent with the changes in the levels of metastasis-related proteins, GP73-OE-SP treatment promoted the migration and invasiveness of HCC cells (Fig. 4E), which decreased in the presence of GP73-KO-SP (Fig. 4F). The gene discussed is GOLM1; the disease is hepatocellular carcinoma.